I use tophat-2.0.10 ,but the -o/--output-dir option is unavailable? That is bug or myself use problem?
Unconfigured Ad
Collapse
X
-
Check you paths and if you have the needed permissions to make that directory. You could have one of the parts of the path wrong or you can’t create a new directory in the directory that tophat_out is going. I don’t think this is a bug, I just used this myself a few days ago (on the newest version).
-
-
-
You should not use options after your input. Otherwise tophat will not recoganize those arguments and use its default ( in your case it created its default directory tophat_out)
Usage: tophat [options]* <genome_index_base> <reads1_1[,...,readsN_1]> [reads1_2,...readsN_2]
You command should look like this:
nohup tophat2 -o Htest_out /share/nas2/heh/data/genome/hs_ref_GRCh37.p5_chr_all.format.fa Htest_1.fq Htest_2.fq &
Comment
-
You are right.Thanks!Originally posted by santhilalsubhash View PostYou should not use options after your input. Otherwise tophat will not recoganize those arguments and use its default ( in your case it created its default directory tophat_out)
Usage: tophat [options]* <genome_index_base> <reads1_1[,...,readsN_1]> [reads1_2,...readsN_2]
You command should look like this:
nohup tophat2 -o Htest_out /share/nas2/heh/data/genome/hs_ref_GRCh37.p5_chr_all.format.fa Htest_1.fq Htest_2.fq &
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:52 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Comment